on the sell side. Often those ASX queries cause more reaction than this - shows great confidence by shareholders and why not.
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market